Cite
NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation
MLA
Castro, Carla Noemi, et al. “NCKAP1L Defects Lead to a Novel Syndrome Combining Immunodeficiency, Lymphoproliferation, and Hyperinflammation.” The Journal of Experimental Medicine, vol. 217, no. 12, Dec. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....1b5d4d587fada4c6d512e3b81b24d9bd&authtype=sso&custid=ns315887.
APA
Castro, C. N., Rosenzwajg, M., Carapito, R., Shahrooei, M., Konantz, M., Khan, A., Miao, Z., Gross, M., Tranchant, T., Radosavljevic, M., Paul, N., Stemmelen, T., Pitoiset, F., Hirschler, A., Nespola, B., Molitor, A., Rolli, V., Pichot, A., Faletti, L. E., … Bahram, S. (2019). NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation. The Journal of Experimental Medicine, 217(12).
Chicago
Castro, Carla Noemi, Michelle Rosenzwajg, Raphael Carapito, Mohammad Shahrooei, Martina Konantz, Amjad Khan, Zhichao Miao, et al. 2019. “NCKAP1L Defects Lead to a Novel Syndrome Combining Immunodeficiency, Lymphoproliferation, and Hyperinflammation.” The Journal of Experimental Medicine 217 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....1b5d4d587fada4c6d512e3b81b24d9bd&authtype=sso&custid=ns315887.